Pharma & Biotech

Pharma & Biotech
  • Michalopoulou and Associates (Lawgroup) advised a multinational pharmaceutical company on the possibility of supplying ATMPs on an ‘out-of-specification’ basis in Greece.

 

  • Michalopoulou and Associates (Lawgroup) advised a multinational healthcare company on pricing and reimbursement of next-generation sequencing tests used in cancerology in Greece.

 

  • Michalopoulou and Associates (Lawgroup) advised a leading pharma company on the establishment and corporate governance of a Biotechnology Park in Greece.

 

  • Michalopoulou and Associates (Lawgroup) composed the internal rules, procedures and policies on the regulatory issues of a multinational pharma company.

 

  • Michalopoulou and Associates (Lawgroup) advised a multinational pharma company before of the Greek Ministry of Health (HTA) regarding the marketing authorosation license of a medicine in the Greek market.

What you can read next

DISCLAIMER

The material on this website is provided for information purposes only. Accessing this information does not create a lawyer-client relationship neither does it constitute legal advice or an opinion on any issue. Downloading and printing copies of the material presented on our website is only permitted for non-commercial, personal, educational purposes provided that the content is not modified. Digital reproduction and distribution of this site or any part thereof is prohibited for all other purposes without prior written consent of Michalopoulou & Assosiates Lawgroup.

CONTACT US

(+30) 210 33 05 230

info@lawgroup.gr

USEFUL LINKS

© 2023 Michalopoulou & Associates Lawgroup. All rights reserved. Powered by AdCreate.

TOP